DBV:EPA
DBV Technologies SA
€2.86
arrow_downward
-4.86%(-0.15) 1D
Jun 5, 4:41:10 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DBV...
Open
€3.00
High
€3.00
Low
€2.84
Mkt. cap
844.00M
Avg. vol.
980.09K
Volume
773.60K
52-wk high
€4.50
52-wk low
€1.37
EPS
-€0.91
Shares outstanding
296.06M
No. of employees
161
Open
€3.00
High
€3.00
Low
€2.84
Mkt. cap
844.00M
Avg. vol.
980.09K
Volume
773.60K
52-wk high
€4.50
52-wk low
€1.37
EPS
-€0.91
Shares outstanding
296.06M
No. of employees
161
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to DBV in the past 3 months
Hold
Buy
1
Hold
0
Sell
1
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for DBV in the last 3 months.
Highest
Current €2.86
€5.50 (+92.31%)
Average
€3.26 (+13.99%)
Lowest
€1.01 (-64.69%)
News stories
From sources across the web
TipRanks
·
1 day ago
DBV Technologies Shareholders Approve Governance and Capital Measures
markets.businessinsider.com
·
1 day ago
DBV Technologies Announces the Results of its 2026 Combined General Meeting
Profile
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
About DBV Technologies SA
AI content may include mistakes. Learn more